FLUCELVAX QUADRIVALENT (PREFILLED SYRINGE) (Influenza A Virus A/Idaho/07/2018 (H1n1) Antigen (Mdck Cell Derived, Propiolactone Inactivated, Influenza A Virus A/Indiana/08/2018 (H3n2) Antigen (Mdck Cell Derived, Propiolactone Inactivated), Influenza B Virus B/Singapore/Inftt-16-0610/2016 Antigen (Mdck Cell Derived, Propiolactone Inactivated), Influenza B Virus B/Iowa/06/2017 Antigen (Mdck Cell Derived, Propiolactone Inactivated)) Injection, Suspension FLUCELVAX QUADRIVALENT (MULTI-DOSE VIAL) (Influenza A Virus A/Idaho/07/2018 (H1n1) Antigen (Mdck Cell Derived, Propiolactone Inactivated, Influenza A Virus A/Indiana/08/2018 (H3n2) Antigen (Mdck Cell Derived, Propiolactone Inactivated), Influenza B Virus B/Singapore/Inftt-16-0610/2016 Antigen (Mdck Cell Derived, Propiolactone Inactivated), Influenza B Virus B/Iowa/06/2017 Antigen (Mdck Cell Derived, Propiolactone Inactivated)) Injection, Suspension [Seqirus, Inc.]

Updated Date: Thu, 03 Oct 2019 00:00:00 EDT
Source: DailyMed Drug Label Updates - Category: Drugs & Pharmacology Source Type: alerts